Elon Musk and Shivon Zilis' relationship has taken an unexpected turn. Zilis, the Neuralink executive who shares four children with Musk, announced on Friday, Oct. 2, that their romantic relationship had ended. Her account suggests the split happened remarkably quickly, with Zilis saying she went from being in love to being "let go" within a week.
"It's hard to go from in love to let go in a week with no warning, but that's just how it is sometimes," Zilis wrote on X. Zilis shared a screenshot of what she presented as an affectionate text conversation with Musk from shortly before the breakup.
Shivon Zilis says her relationship with Elon Musk ended suddenly "with no warning." She shares emotional breakup details, final texts and co-parenting hopes. (@ AFP via Getty Images)
As of Oct. 2, Musk had not publicly responded to Zilis' breakup announcement, according to PEOPLE and Business Insider.
Zilis did not hide the emotional impact of the relationship ending. "I've loved him more than life itself," she wrote, according to Bushttps://www.hola.com/us/ce... Insider. She also said Musk had taught her "100 lifetimes of knowledge" and brought tremendous meaning into her life.

#relationship #shares

Pierpaolo Piccioli presented his Balenciaga Spring 2027 collection on Thursday in front of a packed celebrity front row, bringing together longtime house faces, a few unexpected arrivals and some names I'm very intrigued to see here.
Tiziano Raw
Lauryn Hill might be the person who makes the most sense in this front row. Some will say, yes, but under Demna. However, there is enough edge and plenty of colour in Pierpaolo's Spring 2027 collection to appeal to Ms Hill, although I suspect she'll skip the more romantic looks from the opening section.
Arnold Jerocki/Getty Images for Balenciaga
Shailene Woodley was another person I expected to see in the front row. After the hammering she got for her Balenciaga look at the Emmys, inviting her to Paris and putting her up in a nice hotel was the least they could do.

#front #hill #collection #thursday

Prince Harry is back in the spotlight after his eco-travel initiative, Travalyst, reported a five-figure loss. The Duke of Sussex launched the non-profit venture in 2019 with the goal of making travel more sustainable. Travalyst has maintained that the loss was planned and formed part of an investment in the organization's future.
According to RadarOnline.com, citing Travalyst's latest annual accounts, the organization recorded a loss of around $17,000 (£13,542) in 2025. The result represented a reversal from the previous year's stronger financial position.
A Travalyst spokesperson characterized the deficit as planned and relatively small, saying, "It was a planned and small loss of £13,000, very typical of a lean, not-for-profit organisation, making a critical investment for the future." The spokesperson continued, "Travalyst remains confident in its financial oversight and strength of its partnerships."
Questions surrounding Harry's role in the venture have persisted since 2023. The Duke of Sussex was reportedly absent during the organization's "pilot phase," which saw five new board members join with "world-class expertise." He has also become less visible as the venture's public face, with his most recent appearance in a promotional video dating back to May 2022.
Harry and his wife Meghan Markle's documentary, "Cookie Queens", also reportedly failed at the box office. In an interview with Page Six, royal commentator Kinsey Schofield advised the couple to "disappear professionally."

#planned #sussex

How big of a Knicks fan is Anne Hathaway? When Jimmy Fallon presented her with a hypothetical choice between a second Oscar or another Knicks championship during a Wednesday late night appearance, Hathaway picked the latter. She hesitated — "The way my nervous system is reacting to that choice is really intense," Hathaway said in the moment — but she picked the championship.
So, naturally, the actress, who is expecting her third child with husband Adam Shulman, went through a range of emotions when she was presented with a congratulatory Knicks-themed gift in the middle of her Fallon interview.
First, the NBC host presented her with a signed jersey, which she threw on over her glamorous black dress without hesitation, modeling it for the crowd and keeping it on when she returned to her seat.
Anne Hathaway on "Late Night With Jimmy Fallon" on Sep. 30, 2026 (NBC)
"You are unbelievable," Fallon said, cracking up. "You put it on immediately!"

#fallon #presented #night

Megyn Kelly criticized Mariska Hargitay over her response to a ****** ual ****** ault case involving Cornell University students. During her podcast, Kelly questioned Hargitay's comments and also criticized the outfit worn by the actress's 15-year-old daughter at the 2026 Emmy Awards.
The criticism came after Hargitay spoke out about a case involving a former Cornell student who alleged that seven fraternity members drugged and ****** ually ****** aulted her in October 2024, according to OK! Magazine.
The case drew renewed attention in September after the woman filed a civil lawsuit. The Tompkins County District Attorney later reopened the criminal investigation and said the case would be presented to a grand jury.
Hargitay, who stars in Law & Order: SVU and founded the Joyful Heart Foundation, criticized Cornell's handling of the case. She also shared posts calling for consequences for the accused men, writing, "Yes, I think we should ruin the futures of adult men who drug and gang r— a woman."
Kelly began her podcast segment by discussing Hargitay's career and appearance at the Emmys. Hargitay hosted the ceremony and attended with her family, including her 15-year-old daughter, Amaya.

#case #kelly #cornell

A manager at Childline Liverpool has paid tribute to the charity's "wonderful" founder Dame Esther Rantzen.
Dame Esther, who presented BBC One's show That's Life! for 21 years and launched the charity counselling service for young people 40 years ago, died on Wednesday at the age of 86.
Dame Esther hosted and produced the programme from 1973 to 1994 which regularly attracted 20m viewers for its mix of serious consumer investigations and light-hearted items.
Marian Blackburn, a team leader at Childline Liverpool, said the star was "kind, compassionate and formidable" and everyone was "deeply saddened" at the news.
Dame Esther launched Childline in 1986 and in 2013 set up Silver Line to help elderly people suffering from isolation and loneliness.

#dame #esther #people #wednesday

Puerto Rico is getting ready for one of the biggest nights in Miss Universe history, and now fans are getting their first look at the stage where the next queen will be crowned. The Miss Universe Organization has revealed the stage for the 75th anniversary competition, set for November 24, 2026, at the Coliseo de Puerto Rico José Miguel Agrelot in San Juan.
And this isn't being designed as your typical pageant stage. The futuristic set will feature moving scenic elements, 3D graphics, and advanced lighting and video systems capable of transforming the ***** e throughout the competition. The organization presented the stage concept on September 30, giving fans an early glimpse at the massive production planned for the milestone edition.
Miss Universe 2026 stage revealed: Organization is going big on 75th anniversary (@ Miss Universe)
The reveal is also making clear that Miss Universe is treating its return to Puerto Rico as much more than another final.
One of the most interesting details about the Miss Universe 2026 stage is that it isn't meant to have just one look. The set has been designed to transform as the show progresses.

#stage

Women in Film has revealed its slate of 2026 WIF Honors recipients. This year's honorees — Salma Hayek Pinault, Adria Arjona, Gemma Chan (in absentia), Beth de Araújo, and Pamela Abdy — will be celebrated at the organization's annual benefit gala Nov. 5 at The Beverly Hilton.
Abdy will receive the inaugural Vanguard Award, while Arjona is set to be honored with the Face of the Future Award. Chan and de Araújo will jointly accept the Crystal Award for Advocacy in Film for their collaboration on Josephine, and Hayek Pinault will be presented with the Jane Fonda Humanitarian Award.
More from Gold Derby
Sundance winner 'Josephine' gets emotional, tense 1st teaser trailer, release date
'The Five-Star Weekend' cast and creator reveal missing Season 1 finale scene and tease Greece-set Season 2

#film #arjona #abdy

For the recently reported second quarter, PicS N.V. (NASDAQ:PICS) outperformed relative to its previous guidance across all profitability metrics. The total account base for the company went up to 70.4 million during the second quarter, showcasing a 10% jump from the prior year. Moving on to the bottom line figures, the adjusted earnings before tax, without factoring in costs ******* ociated with stock-based compensation came in at R$291 million for the quarter. This represented a 2.1% outperformance relative to the company's R$285 million guidance. Similarly, compared to the R$245 million projection, adjusted net income for the period actually stood 15.5% higher at R$283 million.
welcomia/Shutterstock.com
The second quarter concluded with strong financial and operating momentum for PicS. The company recorded a 9% annual and 2% sequential growth in its client base, which went up to 45.4 million active users. The total credit portfolio jumped to R$31.9 billion, exceeding management's guidance by 3%. This outperformance came due to a higher number of mature credit card cohorts, and accelerated origination within secured and partly secured categories. An additional factor that accounted for the credit portfolio growth was management's measured expansion into higher risk areas such as newer platform credit and private payroll lending.
Managerial revenue rose to R$3,730 million, topping guidance by 3.6%, and net interest income reached R$2,002 million, 5.4% above projections, boosted by growing credit income. Total cash in totaled R$136.4 billion, up 17% from a year earlier and 9% from the previous quarter, with customers bringing in an average of approximately R$45.4 billion to the platform each month. Total deposits climbed to R$35.8 billion, a 45% yearly jump and 10% quarterly rise.
Some concerns related to the company's loan portfolio emerged during the quarter. Non-performing loans more than 90 days overdue increased to 9.8% of the credit portfolio during the quarter, up 93 basis points sequentially. Stage 3 exposure, which includes a broader set of credit-impaired loans, reached 12.9% of the total credit portfolio.

#million #credit #quarter #Portfolio

On September 9, 2026, Chewy, Inc. (NYSE:CHWY) reported fiscal second-quarter net sales of $3.33 billion, up 7.3% year over year, and adjusted earnings per share of $0.36, nearly double the roughly $0.18 ******* ysts had expected, prompting the company to raise its full-year revenue and profitability outlook. CEO Sumit Singh said the broader pet market did not meaningfully recover during the quarter but also did not deteriorate further, with Chewy continuing to outperform the category by two to three times through share gains across its established and newer businesses.
Chewy, Inc. (NYSE:CHWY)'s recurring revenue base is solid. It gives the company greater visibility into future sales. Autoship sales jumped by 9.3% year over year to $2.82 billion and represented 84.6% of total net sales. The growing contribution from subscription-based purchases gives Chewy a more predictable revenue stream and reduces its exposure to fluctuations in discretionary pet spending.
Chewy is also building growth engines beyond its core retail business. Chewy Health, which includes veterinary care and pharmacy services, delivered triple-digit revenue growth. Specialty categories such as equine and exotics recorded a seventh consecutive quarter of mid-double-digit growth. These businesses give Chewy additional opportunities to increase customer spending and diversify its sources of revenue as the overall pet market matures.
Chewy is combining customer growth with stronger profitability and shareholder returns. The firm added 208,000 net active customers during the quarter. It takes its customer base to 21.7 million while returning $200 million to shareholders through share repurchases. Management also noted structural SG&A leverage, automation, and AI-driven cost reductions as contributors to margin expansion. It shows that Chewy can improve earnings while investing in customer acquisition and growth.
Part of Chewy, Inc. (NYSE:CHWY)'s profitability improvement came from benefits that may not recur. CFO Chris Deppe said the quarter's profitability upside included about $10 million from timing benefits and more than $5 million from discrete benefits. Those items boosted the latest results but do not provide a recurring earnings contribution. It means investors may need to lower their expectations for the pace of margin expansion in future quarters.

#customer

On September 9, 2026, Jersey Mike's Subs Inc. (NYSE:JMKE) reported its first quarterly results as a public company, with total revenue up 10% year over year to $208 million and same-store sales accelerating to 2.3% growth from 1.7% in the prior quarter. It was primarily driven by transaction growth even as the restaurant industry faced weak traffic trends. Net income fell to $37 million from $59 million a year earlier. It showed non-routine expenses, advertising fund timing, and higher interest costs following the company's July initial public offering, partially offset by a $14 million gain on the sale of corporate-owned stores.
Jersey Mike's Subs Inc. (NYSE:JMKE) is gaining customers while its brand remains a major competitive advantage. The firm added 83 stores in the second quarter. It grew its customer base and increased systemwide sales 10% to $1.21 billion. Jersey Mike's also earned the No. 1 ranking among U.S. quick-service restaurant brands in the 2026 American Customer Satisfaction Index, surpassing Chick-fil-A after 11 consecutive years at the top. It gives the newly public company a strong foundation for continued customer and franchisee growth.
The business has substantial whitespace for long-term unit growth. Jersey Mike's ended the quarter with 3,378 locations and maintains a domestic development pipeline of more than 1,600 stores, with more than 90% of that pipeline coming from existing franchisees. Management estimates that the U.S. market could eventually support roughly 7,500 locations and sees potential to reach approximately 15,000 stores globally. It gives the business a long runway for franchise-led revenue and royalty growth.
Digital engagement and transaction growth give Jersey Mike's more avenues to increase sales. Digital sales represented 43% of systemwide sales in the second quarter, up from 41% a year earlier. Same-store sales increased 2.3% mainly because customers placed more transactions. Jersey Mike's also had more than 12.5 million active MyMike's loyalty members in 2025. It provides the company with a large customer database that it can use to increase frequency and personalize marketing as it expands.
Jersey Mike's Subs Inc. (NYSE:JMKE) still faces a significant profitability challenge despite its revenue growth. Second-quarter revenue jumped 10% to $208 million. However, net income fell 37% to $37 million from $59 million a year earlier. Management attributed part of the decline to advertising-fund timing and higher interest expense. It shows that revenue growth has not yet translated into comparable bottom-line growth for shareholders.

#million #customer

The CLARITY Act failed to pass votes in the Senate earlier this week, a piece of legislature that would set out guardrails and ground rules for crypto **** ets in the U.S. With the failure of passage, the Securities and Exchange Commission took matters into its own hands, passing a conditional exemption Thursday for tokenized stocks. This Innovation Exemption allows for a limited type of tokenized securities to trade on specific Tokenized Securities Venues (TSVs), giving them a 5-year runway to prove their trading chops.
Tokenization is one of the latest trends in the investing world, whereby an **** et is represented digitally on a blockchain. It's seen as the next frontier in finance, with digital trading opening up greater access both for a broader investor base as well as the potential to trade 24/7, while also offering the potential for increased efficiency. However, some argue that tokenized **** ets come with added, unique risks and that by moving investments to the blockchain you introduce greater exposure to bad actors in an as-yet unregulated **** e in the U.S. That is, until now.
The SEC exemption allows for a specific type of tokenized stocks to be traded, specifically ones that retain the investor rights of the stock they are tied to (voting and dividends for example). Only tokenized U.S. National Market System (NMS) stocks qualify that trade through U.S. venues who have established standards for who can trade, limit trading volumes to a certain percentage of the stock, and make public their trading activities as well as any affiliates on the TSV. In addition, venues must halt trading when the primary exchange halts, and leverage is not permitted. Any company that does not want tokenized shares has 30 days to object and prevent their shares from being created.
It's important to note that currently there are two main types of tokenized securities, those that are directly linked to the **** et they represent digitally and those that provide synthetic exposure. Of the two, only the direct exposure tokenized stocks qualify that meet all of the exemption's restrictions.
"The Commission is not cementing today's technology as the standard for tomorrow. Instead, it is allowing the market to evolve, monitoring its development, and using that insight to inform a nimbler and future-ready regulatory framework," SEC Chair Paul Atkins said in a statement.

#exposure #commission

For the recently reported second quarter, PicS N.V. (NASDAQ:PICS) outperformed relative to its previous guidance across all profitability metrics. The total account base for the company went up to 70.4 million during the second quarter, showcasing a 10% jump from the prior year. Moving on to the bottom line figures, the adjusted earnings before tax, without factoring in costs ****** ociated with stock-based compensation came in at R$291 million for the quarter. This represented a 2.1% outperformance relative to the company's R$285 million guidance. Similarly, compared to the R$245 million projection, adjusted net income for the period actually stood 15.5% higher at R$283 million.
welcomia/Shutterstock.com
The second quarter concluded with strong financial and operating momentum for PicS. The company recorded a 9% annual and 2% sequential growth in its client base, which went up to 45.4 million active users. The total credit portfolio jumped to R$31.9 billion, exceeding management's guidance by 3%. This outperformance came due to a higher number of mature credit card cohorts, and accelerated origination within secured and partly secured categories. An additional factor that accounted for the credit portfolio growth was management's measured expansion into higher risk areas such as newer platform credit and private payroll lending.
Managerial revenue rose to R$3,730 million, topping guidance by 3.6%, and net interest income reached R$2,002 million, 5.4% above projections, boosted by growing credit income. Total cash in totaled R$136.4 billion, up 17% from a year earlier and 9% from the previous quarter, with customers bringing in an average of approximately R$45.4 billion to the platform each month. Total deposits climbed to R$35.8 billion, a 45% yearly jump and 10% quarterly rise.
Some concerns related to the company's loan portfolio emerged during the quarter. Non-performing loans more than 90 days overdue increased to 9.8% of the credit portfolio during the quarter, up 93 basis points sequentially. Stage 3 exposure, which includes a broader set of credit-impaired loans, reached 12.9% of the total credit portfolio.

#million #total

On September 14, during the episode of Mad Money, Jim Cramer said CrowdStrike Holdings, Inc. (NASDAQ:CRWD) is emerging as a beneficiary of growing concerns over the cybersecurity risks created by artificial intelligence, as he said:
Over the weekend, the co-founder and CEO of Anthropic published an essay where he pushed for a slowdown among the frontier AI labs in order to handle newfound security concerns. In response to that, the cybersecurity cohort just went crazy because there are the companies that can prevent AI agents from randomly hacking into networks all over the world, and it's the cybersecurity companies. Take CrowdStrike, which shot up nearly 14% today, leading the S&P 500, something I feel great about, of course, because we own it big for the Charitable Trust. These guys have been adamant that AI represented a great opportunity for their business, and now Wall Street's finally gotten the memo.
CrowdStrike Holdings, Inc.'s (NASDAQ:CRWD) second-quarter fiscal 2027 revenue increased 26% year over year to $1.47 billion, while ending annual recurring revenue rose 25% to $5.84 billion. Net new ARR reached a record $332.8 million, and free cash flow was $377.4 million. The company also raised its full-year fiscal 2027 net new ARR growth outlook to 34% at the midpoint, up 630 basis points. CEO George Kurtz said the company believes securing AI is its "largest market opportunity in our history."
Kurtz said on September 14 that AI-driven threats are already operating at machine speed, describing the emerging threat as autonomous campaigns rather than individual hackers. He identified endpoints, cloud workloads and SaaS as key battlegrounds and said "enforcement at machine speed" is needed to stop AI agents in motion. CrowdStrike has responded by expanding into AI-agent, model and infrastructure protection, including Continuous Identity for AI Agents and Falcon AI Detection and Response.
CrowdStrike Holdings, Inc.'s (NASDAQ:CRWD) valuation leaves little room for a meaningful slowdown in growth. Yahoo Finance currently shows a forward P/E of approximately 188.7 times and a price-to-sales ratio of roughly 44.6 times. Those multiples leave little room for a material slowdown in ARR growth, weaker adoption of newer products, or greater competitive pressure. The company also remains much less profitable on a GAAP basis than its adjusted results suggest. The company reported a $33.2 million GAAP operating loss in the latest quarter against $371.6 million of non-GAAP operating income, while stock-based compensation and related employer payroll taxes totaled $399 million.

#crwd

High Tide Inc. (NASDAQ:HITI) reported record fiscal third-quarter revenue of C$198.8 million on September 14, up 33% year over year. Operating income increased 133% to C$8.7 million for the quarter ended July 31, 2026, yet net cash provided by operating activities slipped to C$10.1 million from C$10.7 million.
High Tide Inc. (NASDAQ:HITI) generated C$11.9 million of operating cash flow before changes in non-cash working capital, up 44%. Working capital then absorbed C$1.8 million, compared with a C$2.4 million release a year earlier. That approximately C$4.2 million unfavorable swing outweighed the improvement before working-capital movements. The question is whether expansion will keep requiring a larger cash commitment.
High Tide Inc. (NASDAQ:HITI) is translating sales growth into stronger operating profitability. Operating income represented approximately 4.4% of revenue, compared with 2.5% a year earlier. That improvement gives the business more room to absorb the costs of expansion.
High Tide Inc. (NASDAQ:HITI) opened four Canadian stores and acquired four more during the quarter. Its German medical-cannabis subsidiary, Remexian, generated C$38.2 million in revenue, up from C$31.6 million sequentially. Remexian distributed 10.2 tonnes, a 35% sequential increase. Both markets offer opportunities to build sales across a larger operating base.
High Tide Inc. (NASDAQ:HITI) also improved operating cash flow to C$4.4 million in the second quarter. For the first nine months, operating cash flow reached C$20.4 million versus C$19.6 million a year earlier. Those comparisons show that the quarterly year-over-year decline sits alongside improving cash generation over other periods.

#high

He was the sole holdout on a 12-person jury who otherwise voted to acquit Lindsay Clancy of murdering her three children — frustrating the defense and causing a mistrial.
After seven days of deliberations, and with specific instructions from Judge William Sullivan to follow the letter of the law on reasonable doubt, the jury said it still had one holdout who refused to budge. A mistrial was declared on Sept. 4.
Now, the lone juror, named Michael Desronvil, has come forward to share his side of the story, saying that he "didn't have any doubts" that Clancy was criminally responsible for the killings.
In a statement shared with Yahoo on Sept. 18 by his attorney Edward Andrew Paltzik, Desronvil said: "I didn't have any doubts. As I tried to explain different possible theories during deliberation, I kept getting cut off as if I had doubts based on the evidence presented.
"Based on all the physical evidence, key witnesses, and what the prosecution presented, I thought it was enough proof that she (Clancy) knew exactly what she was doing and planned."

#clancy #evidence

Cognyte Software Ltd. (NASDAQ:CGNT) reported on September 9 that revenue for the fiscal second quarter ended July 31, 2026, increased 12.0% to $109.2 million. Total software revenue, comprising software and software services, rose 20.9% to $100.8 million.
Company-defined non-GAAP adjusted EBITDA increased 35.7% to $14.9 million. The measure adds depreciation, amortization, stock-based compensation, restructuring costs, and other specified adjustments to GAAP operating income. Yet quarterly billings fell to $76.3 million from $93.0 million. The central question is whether a more profitable revenue mix can produce stronger cash generation while sustaining future growth.
The portfolio transition is visible in the revenue base. Total software revenue represented more than 92% of sales. Recurring revenue, primarily support contracts and subscription offerings, reached $56.2 million, or 51.4% of total revenue.
For Cognyte Software Ltd. (NASDAQ:CGNT), a larger recurring base could make revenue more predictable and support continued product investment. Renewals also create opportunities to expand customer relationships without rebuilding the sales pipeline from scratch. The benefit depends on retention and expansion within those accounts.
Profitability improved under both accounting measures. GAAP operating margin increased to 4.3% from 2.8%, while adjusted EBITDA margin expanded to 13.6% from 11.3%. That combination strengthens the case that the transition is improving operating economics, even after recognizing expenses excluded from adjusted results.

#gaap #NASDAQ

The choice between established ****** ans and digital-first challengers defines many modern portfolios. In the financial realm, investors must decide if JPMorgan Chase (NYSE:JPM) or SoFi Technologies (NASDAQ:SOFI) is the better buy for long-term growth.
JPMorgan Chase operates as a global financial heavyweight, offering everything from wealth management to retail branches. Conversely, SoFi Technologies focuses on an integrated mobile app to help members borrow, save, and invest. While one relies on massive scale, the other bets on fintech innovation to capture a younger, tech-savvy demographic.
JPMorgan Chase functions as a cornerstone of the global economy, managing a vast array of services including ****** et management and investment banking. In its latest annual report, filed for 2025, the firm highlighted its reach through more than 5,000 branches across the 48 contiguous states. It serves a diverse client base ranging from individual consumers and small businesses to large corporations and governments. The firm provides a comprehensive range of financial services, including transaction processing and commercial banking on a global scale.
Financial performance remained robust in FY 2025, with revenue reaching nearly $182.4 billion. This represented a growth rate of approximately 3.3% compared to the previous year, contributing to a net income of close to $57.0 billion. The net margin, which measures the percentage of revenue kept as profit after all expenses, sat at roughly 20.4% for the period. This consistent profitability underscores the scale of its operations across diverse global markets.
As of its December 2025 balance sheet, the firm reported a debt-to-equity ratio of nearly 2.6x. This ratio measures total debt against shareholder equity, with a higher number indicating more reliance on borrowed funds to finance growth. The current ratio, which compares short-term ****** ets to short-term liabilities, was approximately 0.5x, while free cash flow reached a negative $147.8 billion. Free cash flow is the cash a company generates after accounting for cash outflows to support operations and maintain its capital ****** ets.

#sofi #global #term

Eli Lilly and Company (NYSE:LLY) says its newly launched oral obesity drug Foundayo has captured more than 30% of new U.S. patients starting oral weight-loss medicines, a notable early gain against Novo Nordisk's Wegovy pill. Reuters reports that Wegovy initially held roughly 90% of the oral market, making Lilly's rapid share capture an important sign that the oral GLP-1 market is becoming a two-player competition rather than a Novo-dominated segment. The broader U.S. obesity-drug market is expected to exceed $100 billion annually by 2030, with oral treatments potentially accounting for more than one-third of GLP-1 use.
The timing is strategically important for Lilly because Foundayo was only launched in the U.S. in April 2026. The drug starts at $149 per month for self-pay patients and can cost as little as $25 for eligible commercially insured patients, while Medicare beneficiaries can access it through the GLP-1 Bridge program at $50 per month. Lilly's SEC filing says Mounjaro and Zepbound already represented 65% of its revenue in the first six months of 2026, highlighting both the importance of the incretin franchise and the opportunity for Foundayo to broaden Lilly's cardiometabolic revenue base.
The strongest bullish implication is that Foundayo appears to be overcoming the biggest behavioral barrier in obesity treatment: patients' preference for an oral medicine over an injection. Capturing more than 30% of new oral patients only months after launch suggests Eli Lilly and Company (NYSE:LLY) is establishing meaningful competitive positioning before the oral GLP-1 market fully scales. Foundayo's formulation also has a practical advantage because it can be taken at any time of day without food or water restrictions, while Lilly's clinical data showed an average 27.3-pound, or 12.4%, weight reduction at the highest dose among patients who remained on treatment in ATTAIN-1.
The commercial opportunity could become considerably larger if Foundayo gains indications beyond obesity. Lilly reported that in the ACHIEVE-3 trial, Foundayo produced a 57.1% greater relative reduction in A1C and a 73.6% greater relative reduction in body weight compared with oral semaglutide 14 mg. Lilly submitted Foundayo for type 2 diabetes in the U.S., EU, and **** an, potentially expanding the addressable market beyond weight management.
The early oral-market traction also complements Eli Lilly and Company (NYSE:LLY)'s existing injectable franchise rather than simply cannibalizing it. A Lilly trial found that patients switching from maximum-tolerated Wegovy to Foundayo maintained all but 0.9 kg of their previous weight loss after one year, while patients switching from maximum-dose Zepbound to Foundayo maintained all but 5.0 kg. That suggests Foundayo could serve as a maintenance or lower-burden treatment within Lilly's broader obesity portfolio, increasing lifetime value per patient rather than limiting the opportunity to new prescriptions.

#patients #weight #c

Anthropic could reportedly complete an initial public offering (IPO) by early November, which could fetch a valuation of roughly $2 trillion. Amazon (NASDAQ: AMZN) and Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) are two stocks positioned to benefit if Anthropic goes public.
Anthropic said its annualized revenue reached $47 billion in May, up from the $14 billion run rate it disclosed on Feb. 12, 2026. That helped push its valuation to $965 billion on May 28, following a $65 billion Series H round led by Altimeter Capital, Dragoneer, Greenoaks, and Sequoia Capital.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Amazon and Alphabet hold minority stakes, providing investors with some exposure to Claude's growth. Moreover, if Anthropic does go public, it could raise additional capital to support the massive compute commitments it's already making with Amazon and Google.
In its second-quarter earnings release, Amazon reported that net income surged 244% year over year to $62.6 billion. A key driver was a $53.4 billion non-operating pre-tax gain recognized as "other income," which the company attributed primarily to its investment in Anthropic. This gain reflected the recent increase in valuation for Anthropic following its latest funding round. The gain represented 2% of Amazon's market cap at the time of the second-quarter earnings release.

#NVIDIA #capital #signal #valuation

The aerospace industry is evolving as Boeing (NYSE:BA) attempts a massive operational turnaround while Rocket Lab (NASDAQ:RKLB) rapidly expands its footprint across the global ******* e economy.
Boeing remains a dominant force in commercial aviation and defense, whereas Rocket Lab specializes in small-satellite launches and ******* ecraft components. Investors often compare them to decide between an established giant recovering from crisis and a high-growth challenger in the private ******* e sector.
Boeing operates as a massive player among defense stocks and commercial aviation leaders, manufacturing everything from the 737 Max to advanced military rotorcraft. The company generates revenue through commercial aircraft sales, defense contracts with the U.S. Department of Defense and NASA, and global services. Customer concentration like this adds a layer of risk to the business. In 2025, the company acquired Spirit AeroSystems to address long-standing quality issues, providing transition services to other buyers like Airbus (OTC:EADSF).
In FY 2025, revenue reached nearly $89.5 billion, representing a growth of roughly 34.5% over the previous year. The company reported a net income of approximately $2.2 billion, a significant recovery from the net loss of nearly $11.8 billion in FY 2024. This improvement in the net margin to 2.5% suggests the company is beginning to stabilize its bottom line after years of heavy losses.
As of its December 2025 balance sheet, Boeing carries a debt-to-equity ratio of nearly 10.0x, a measure comparing total debt to shareholder equity that indicates a heavy reliance on borrowing. The company reported a current ratio of nearly 1.2x, which measures a company's ability to cover its short-term debts with liquid ******* ets. Note that stock-based compensation represented roughly 40% of operating cash flow, which inflates reported cash generation since SBC is a non-cash expense added back in the cash flow statement. The company also generated a negative free cash flow of approximately $1.9 billion, representing operating cash minus spending on physical ******* ets.

#boeing #nearly #rocket

Eli Lilly and Company (NYSE:LLY) says its newly launched oral obesity drug Foundayo has captured more than 30% of new U.S. patients starting oral weight-loss medicines, a notable early gain against Novo Nordisk's Wegovy pill. Reuters reports that Wegovy initially held roughly 90% of the oral market, making Lilly's rapid share capture an important sign that the oral GLP-1 market is becoming a two-player competition rather than a Novo-dominated segment. The broader U.S. obesity-drug market is expected to exceed $100 billion annually by 2030, with oral treatments potentially accounting for more than one-third of GLP-1 use.
The timing is strategically important for Lilly because Foundayo was only launched in the U.S. in April 2026. The drug starts at $149 per month for self-pay patients and can cost as little as $25 for eligible commercially insured patients, while Medicare beneficiaries can access it through the GLP-1 Bridge program at $50 per month. Lilly's SEC filing says Mounjaro and Zepbound already represented 65% of its revenue in the first six months of 2026, highlighting both the importance of the incretin franchise and the opportunity for Foundayo to broaden Lilly's cardiometabolic revenue base.
The strongest bullish implication is that Foundayo appears to be overcoming the biggest behavioral barrier in obesity treatment: patients' preference for an oral medicine over an injection. Capturing more than 30% of new oral patients only months after launch suggests Eli Lilly and Company (NYSE:LLY) is establishing meaningful competitive positioning before the oral GLP-1 market fully scales. Foundayo's formulation also has a practical advantage because it can be taken at any time of day without food or water restrictions, while Lilly's clinical data showed an average 27.3-pound, or 12.4%, weight reduction at the highest dose among patients who remained on treatment in ATTAIN-1.
The commercial opportunity could become considerably larger if Foundayo gains indications beyond obesity. Lilly reported that in the ACHIEVE-3 trial, Foundayo produced a 57.1% greater relative reduction in A1C and a 73.6% greater relative reduction in body weight compared with oral semaglutide 14 mg. Lilly submitted Foundayo for type 2 diabetes in the U.S., EU, and ***** an, potentially expanding the addressable market beyond weight management.
The early oral-market traction also complements Eli Lilly and Company (NYSE:LLY)'s existing injectable franchise rather than simply cannibalizing it. A Lilly trial found that patients switching from maximum-tolerated Wegovy to Foundayo maintained all but 0.9 kg of their previous weight loss after one year, while patients switching from maximum-dose Zepbound to Foundayo maintained all but 5.0 kg. That suggests Foundayo could serve as a maintenance or lower-burden treatment within Lilly's broader obesity portfolio, increasing lifetime value per patient rather than limiting the opportunity to new prescriptions.

#weight

You can find original article here WealthManagement. Subscribe to our free daily WealthManagement newsletters.
The news that the giant AI technology provider Anthropic launched Claude for Financial Advisors was received with some skepticism by industry **** ysts, but overall, many wealth management technology providers and consultants shared their excitement and enthusiasm, noting that the company had presented them with something that could, if implemented well, solve many issues with current advisor tech stacks.
"I find it positive that Anthropic has sent these signals to the market and it is good for the industry overall," said longtime **** yst Alois Pirker, who is now the CEO of his own consultancy, Pirker Partners.
"Nonetheless, my sense is that Claude will hit the same problem as Salesforce, getting to the level of specificity that financial advisors need," he said, referring to the behemoth CRM provider and its initial rollout of Salesforce for Financial Services, which reached general availability a decade ago (and later changed its name to Salesforce Financial Services Cloud).
One way in which the technology industry responded to advisors' desire for such specificity was the development of the specialized and popular advisor CRM product Practifi, he said, which is built on top of Salesforce and caters to certain types of firms in need of more customization.

#financial #advisors #wealthmanagement

Emilia Clarke returned to the Emmy Awards this evening, where she reunited with Emma D'Arcy for a Game of Thrones and House of the Dragon crossover moment as they presented Outstanding Lead Actress in a Limited or Anthology Series or Movie.
LISA O'CONNOR / AFP via Getty Images
Lilac is the unexpected colour of the night, with Florence Pugh and Sarah Pidgeon wearing the same hue, but sadly, the colour is where my enthusiasm ends with this Prada gown.
And the issues remain the same. I feel like I'm just repeating myself at this point.
Have a signature by all means with this silhouette, which in this case comes with a cape-style back featuring symmetrical bows, but when the tailoring and fabric – this time silk faille – consistently become the main talking points for the wrong reasons, it's just disappointing for such a big brand.

#game

The Oklahoman's high school team of the week poll for Sept. 7-13 presented by Homeland is now live at oklahoman.com.
Last week's winner was Dover boys cross country.
Fans have the opportunity to vote among five standout teams in the Oklahoma City metro area.
Voting is open until noon Sunday.
Here are the nominees.

#last

The Oklahoman's fall girls sport athletes of the week poll for Sept. 7-13 presented by Landmark Fine Homes is now live at oklahoman.com.
Last week's winner was Classen SAS softball player Sarai Freelen, who earned 1,641 votes.
Voting is open until noon Sunday.
Here are this week's nominees.
More: Oklahoma high school softball storylines, players to watch for 2026 fastpitch season

#softball #voting

Dispatch.com readers can vote for their favorite boys high school athletes of the week on their desktop, the Dispatch.com mobile web or Dispatch app once per hour by scrolling down to ballots listed below.
Deadline is 4 p.m. Friday, Sept. 18.
The Ohio State University Wexner Medical Center high school Athlete of the Week voting occurs each week during high school sports competition and recognizes athletes across all sports.
Last week's Athlete of the Week: Berlin's Ethan Litton voted Boys Athlete of the Week presented by Wexner Medical Center
If you can't see the ballot when you scroll to the bottom of this story, try refreshing the link or clearing the cache in your browser. You do not have to be a subscriber to vote.

#wexner #medical

Ja'Marr Chase, George Pickens and other fantasy football bad beats not to worry about appeared first on ClutchPoints. Add ClutchPoints as a Preferred Source by clicking here.
Week 1 can make fantasy managers question an entire summer of research. A first-round receiver disappears, a breakout candidate misses his projection and suddenly the trade block looks tempting. The better approach is to separate disappointing box scores from genuinely concerning roles. Ja'Marr Chase and George Pickens hurt lineups in Week 1, but neither performance provided a good reason to panic.
Mandatory Credit: Denny Medley-Imagn Images
Chase delivered the most shocking dud of the opening weekend, catching two of four targets for only 12 yards in Cincinnati's 33-27 victory over Tampa Bay. He finished behind Mike Gesicki, Tee Higgins and Chase Brown in targets despite entering the week as fantasy football's consensus top wide receiver.
The four targets were frustrating, but the result looks more like an outlier than a changing offensive hierarchy. Chase's 3.2 PPR points represented the second-worst fantasy performance of his career. He has also averaged 5.5 fewer fantasy points in September than during every other month, demonstrating that slow starts are nothing new.

#fantasy #george #receiver

Prince Harry might be back in the UK, but that doesn't mean he's returned to royal duties. In fact, both Harry and his father, King Charles, have made it clear that he is not a working royal and likely won't ever be again. Proof of that is that Harry was not invited to the funeral of Norway's King Harald.
William represented the British royal family and walked behind the monarch's coffin on Wednesday, September 9. He was accompanied by Princess Anne for the procession, which extended from the Royal Palace to Oslo Cathedral. Other foreign royals present included King Felipe VI and Queen Letizia of Spain, as well as King Carl XVI Gustaf and Queen Silvia of Sweden and King Frederik X and Queen Mary of Denmark.
More from StyleCaster
'Wounded' Harry Reportedly 'Blames' Charles for Devastating Business 'Withdrawal'-He Feels 'Injured'
William Reportedly 'Disturbed' by Harry's 'Vulgar' Act-It's a 'Betrayal'

#prince #harald

It's time to take a look at the standout performers from the past week of the volleyball season.
We'd like you to choose the lohud Volleyball Player of the Week, presented by White Plains Hospital. Finalists and their credentials are listed below. The poll will remain open until 3 p.m. Wednesday, Sept. 16. The winner will be announced Wednesday on lohud sports social media.
Nominees are based on play from Sept. 7-13.
Past winners: Michaela Lopane, Harrison.
Let's meet the candidates.

#week #lohud #white